DeepMed Research

PRISMA HEALTH-MIDLANDS

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website: http://prisma-i.it

Clinical Trials

HP Arize 3D Orthotics for Planar Fasciitis

Not Applicable

Conditions: Plantar Fascitis

Interventions: Device: Traditional Orthotics
Device: HP Arize 3D-Printed Orthotics

First Posted Date: 2023-01-31

Last Posted Date: 2025-03-14

Lead Sponsor: Prisma Health-Midlands

Target Recruit Count: 30

Registration Number: NCT05707013

Locations: 🇺🇸
Prisma Health - Midlands, Lexington, South Carolina, United States

Zero Degree Knee Positioner for Improved Earley Knee Extension Following Total Knee Arthroplasty

Not Applicable

Conditions: Osteoarthritis, Knee

Interventions: Device: Zero Degree Knee Positioner

First Posted Date: 2023-01-10

Last Posted Date: 2025-03-14

Lead Sponsor: Prisma Health-Midlands

Target Recruit Count: 154

Registration Number: NCT05678231

Locations: 🇺🇸
Prisma Health - Midlands, Columbia, South Carolina, United States

Immunonutrition for Diabetic Foot Ulcers

Phase 2

Terminated

Conditions: Diabetes Mellitus
Diabetic Peripheral Neuropathy
Diabetic Foot Ulcer

Interventions: Drug: Lovaza
Drug: L-Arginine Powder
Drug: Vitamin C

First Posted Date: 2022-03-16

Last Posted Date: 2024-12-27

Lead Sponsor: Prisma Health-Midlands

Target Recruit Count: 1

Registration Number: NCT05281562

Locations: 🇺🇸
Prisma Health, Columbia, South Carolina, United States

Astaxanthin for Management of Inflammation in Knee Osteoarthritis

Phase 2

Terminated

Conditions: Osteoarthritis, Knee
Osteoarthritis Knees Both
Joint Inflammation

Interventions: Other: Placebo
Drug: Astaxanthin

First Posted Date: 2021-12-01

Last Posted Date: 2025-05-20

Lead Sponsor: Prisma Health-Midlands

Target Recruit Count: 16

Registration Number: NCT05138549

Locations: 🇺🇸
Prisma Health, Columbia, South Carolina, United States

Temporal Profile of Serum Vitamin D Levels in Foot and Ankle Fusion Surgery

Early Phase 1

Conditions: Ankle Arthrodesis
MTP Arthrodesis

Interventions: Drug: Vitamin D3

First Posted Date: 2021-02-26

Last Posted Date: 2025-03-14

Lead Sponsor: Prisma Health-Midlands

Target Recruit Count: 90

Registration Number: NCT04772196

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
Prisma Health, Columbia, South Carolina, United States

Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study

Completed

Conditions: Hammertoe
Bunion of Unspecified Foot
Ankle Fractures
Achilles Tendon Surgery
Bunionette of Unspecified Foot

Interventions: Drug: Acetominophen
Drug: Toradol
Drug: Meloxicam
Drug: Cyclobenzaprine
Drug: Lyrica

First Posted Date: 2021-02-25

Last Posted Date: 2023-04-27

Lead Sponsor: Prisma Health-Midlands

Target Recruit Count: 72

Registration Number: NCT04771741

Locations: 🇺🇸
Prisma Health Midlands, Columbia, South Carolina, United States

Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination

Early Phase 1

Withdrawn

Conditions: Anoxic Brain Injury
Brain Death
Cardiac Arrest
Sedative Intoxication
Narcotic Intoxication

Interventions: Drug: Flumazenil
Drug: Naloxone

First Posted Date: 2018-11-16

Last Posted Date: 2024-10-31

Lead Sponsor: Prisma Health-Midlands

Registration Number: NCT03743805

Locations: 🇺🇸
PRISMA Health Midlands, Columbia, South Carolina, United States

Vitamin D3 Supplementation and Stress Fracture Occurrence in High-Risk Collegiate Athletes

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Stress Fracture
Athletic Injuries
Orthopedic Disorder

Interventions: Dietary Supplement: Cholecalciferol (Vitamin D3)

First Posted Date: 2018-01-10

Last Posted Date: 2018-01-10

Lead Sponsor: Prisma Health-Midlands

Target Recruit Count: 118

Registration Number: NCT03395171

N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome

Early Phase 1

Withdrawn

Conditions: Acute Respiratory Distress Syndrome

Interventions: Drug: N-acetyl cysteine

First Posted Date: 2017-11-17

Last Posted Date: 2024-10-31

Lead Sponsor: Prisma Health-Midlands

Registration Number: NCT03346681

Locations: 🇺🇸
Palmetto Health Richland, Columbia, South Carolina, United States

Early Intrapleural TPA Instillation Versus Late

Phase 4

Withdrawn

Conditions: Tissue Plasminogen Activator

Interventions: Combination Product: early tPA and DNase

First Posted Date: 2017-05-25

Last Posted Date: 2025-02-21

Lead Sponsor: Prisma Health-Midlands

Registration Number: NCT03167281

Locations: 🇺🇸
Palmetto Health Richland, Columbia, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy